Zymeworks Inc (NY: ZYME )
6.430 UNCHANGED Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
All News about Zymeworks Inc
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...
Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2022
January 19, 2022
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus EyePoint Announces Commercialization Agreement For Dexycu To Treat Post-...
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Exposures Product Safety
Friday Markets Coverage
November 19, 2021
Zymeworks Names Neil Josephson, M.D., Chief Medical Officer
November 09, 2021
Zymeworks to Present at Upcoming Investor Conferences
November 08, 2021
Zymeworks Reports 2021 Third Quarter Financial Results
November 03, 2021
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following